Multiple ascending dose study of BMS-790052, a nonstructural protein 5A replication complex inhibitor, in patients infected with hepatitis C virus genotype 1 (Q43039677)

From Wikidata

Jump to navigation Jump to search

scientific article published on December 1, 2011

Language	Label	Description	Also known as
English	Multiple ascending dose study of BMS-790052, a nonstructural protein 5A replication complex inhibitor, in patients infected with hepatitis C virus genotype 1	scientific article published on December 1, 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Multiple ascending dose study of BMS-790052, a nonstructural protein 5A replication complex inhibitor, in patients infected with hepatitis C virus genotype 1 (English)

1 reference

10.1002/HEP.24609

https://api.crossref.org/works/10.1002/HEP.24609

9 December 2024

Hepatitis C virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Min Gao

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Marc Bifano

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Ellen Chung

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Anna Persson

5

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Ronald Goldwater

7

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Maribel Rodriguez-Torres

9

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Apinya Vutikullird

10

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Ernesto Fuentes

11

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Eric Lawitz

12

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Juan Carlos Lopez-Talavera

13

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Richard E. Nettles

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21837752

9 December 2024

Thomas C. Marbury

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21837752

9 December 2024

Michael P. DeMicco

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21837752

9 December 2024

Dennis M. Grasela

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21837752

9 December 2024

language of work or name

0 references

publication date

1 December 2011

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

December 2011

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21837752

9 December 2024

full work available at URL

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hep.24609

Portable Document Format

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21837752

9 December 2024

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fhep.24609

1 reference

10.1002/HEP.24609

https://api.crossref.org/works/10.1002/HEP.24609

9 December 2024

https://journals.lww.com/01515467-201112000-00009

1 reference

10.1002/HEP.24609

https://api.crossref.org/works/10.1002/HEP.24609

9 December 2024

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

54

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

1956-1965

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Diagnosis, management, and treatment of hepatitis C: an update

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24609

21 January 2018

Recent progress in the development of selected hepatitis C virus NS3.4A protease and NS5B polymerase inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24609

21 January 2018

Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24609

21 January 2018

Resistance analysis of the hepatitis C virus NS5A inhibitor BMS-790052 in an in vitro replicon system

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24609

21 January 2018

Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24609

21 January 2018

Rapid decline of viral RNA in hepatitis C patients treated with VX-950: a phase Ib, placebo-controlled, randomized study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24609

21 January 2018

Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24609

21 January 2018

Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24609

21 January 2018

Antiviral activity of telaprevir (VX-950) and peginterferon alfa-2a in patients with hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24609

21 January 2018

Hepatitis C virus NS5A: tales of a promiscuous protein

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24609

21 January 2018

Identifiers

10.1002/HEP.24609

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43039677&oldid=2285296189"